How Long Do You Stay on 0.5mg Wegovy?

The myth: 0.5mg is too low to do anything useful

A question our prescribers hear regularly is whether the lower doses of Wegovy are pointless, a formality before reaching the "real" dose. It's understandable. People starting treatment want results, and 0.5mg sounds modest compared to the 2.4mg maintenance figure quoted in the headlines.

The reality is more considered. The titration schedule exists because semaglutide slows gastric emptying and adjusts appetite signalling through GLP-1 receptors, and that adjustment can be rough if the dose climbs too fast. Nausea, loose stools and fatigue are the most commonly reported early side effects, as the NHS semaglutide medicines page explains. Stepping up gradually gives your gut time to adapt. The 0.5mg dose is doing something, it's just not doing everything yet.

Some people notice early changes in appetite and fullness even at this stage. Others feel little difference and are impatient to move up. Both responses are normal, and neither is a reason to skip ahead.

How long four weeks at 0.5mg actually looks in practice

The standard Wegovy titration schedule runs in roughly four-week blocks at each dose: 0.25mg, then 0.5mg, then 1.0mg, then 1.7mg, then 2.4mg as the licensed maintenance dose. You can read through the full dose sequence on the Wegovy doses page if you want the complete picture.

At 0.5mg, four weeks means four weekly injections before your prescriber reviews whether to increase. In practice that might feel like a single month on a pen that's sitting in the fridge door alongside the other weekly medications in your household, easy to forget how structured the process is when it's built into a quiet routine.

The four-week figure is the standard, but it isn't a guarantee. If side effects at 0.5mg have been more disruptive than expected, a prescriber may recommend staying at that dose for a further four weeks before stepping up, and our page on how long you stay on 0.25 Wegovy explains how that same principle applies at the very first stage of titration. NICE's appraisal of semaglutide for weight management (TA875) is clear that treatment is intended to be personalised within the framework of a supervised programme, the schedule guides; it doesn't override clinical assessment.

When staying at 0.5mg longer makes sense

There are genuine reasons a prescriber might extend the 0.5mg phase beyond the standard four weeks. Persistent nausea that hasn't settled, significant gastrointestinal disruption, or a period of illness during the titration window can all prompt a pause at the current dose. This is not unusual and doesn't affect whether the treatment will eventually work at higher doses.

What matters is that any extension is agreed with your prescriber, not decided independently. Adjusting your own titration (skipping a dose, going back down, or pushing ahead) isn't recommended, because the dose schedule has been designed to balance tolerability with effectiveness. If you're unsure whether your current dose is right for where you are in treatment, that's a conversation to have with the clinical team supporting you, not a decision to make from a forum or a side-by-side comparison of other people's timelines.

For context on what happens once you reach the end of the titration schedule, the page on how long you can stay on Wegovy 2.4mg covers the evidence around maintenance and duration. And if you're wondering whether staying permanently at a lower dose is ever appropriate, whether you can stay on 0.5mg Wegovy long-term addresses that question directly.

What this means if you're considering starting Wegovy

Understanding the titration schedule before you begin treatment helps set realistic expectations. The first several weeks are about tolerability, not peak results. You won't be at a maintenance dose for at least four to five months if the standard schedule is followed, and the results seen in clinical trials (around 15% average body-weight reduction over 68 weeks in the STEP 1 study) reflect what happens across the full treatment period, not just the early phases.

If you're weighing up whether Wegovy is the right option for you, or wondering how the schedule fits your circumstances, the Wegovy treatment page gives a thorough overview of how the medicine works and who it's licensed for. You can also explore the broader context of weight-loss treatment options available through a regulated UK pharmacy. Private treatment through a service like ours means no waiting list and no GP referral needed, you'd complete a free consultation, a GPhC-registered prescriber reviews it the same day, and if treatment is clinically appropriate, your prescription is issued. Take a look at the Wegovy dosage amounts page for a clear breakdown of each step in the schedule, or check your eligibility to speak to our prescribers.